Brief: Catalyst Biosciences Posts Quarterly Loss Per Share $0.65

Gyre Therapeutics

31/03/2022 13:47

March 31 (Reuters) - Catalyst Biosciences Inc  CBIO.O :
    * CATALYST BIOSCIENCES REPORTS FOURTH QUARTER AND YEAR-END
2021
OPERATING & FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
    * CATALYST BIOSCIENCES INC - QTRLY LOSS PER SHARE $0.65
    * CATALYST BIOSCIENCES INC - CASH, CASH EQUIVALENTS, AND,
INVESTMENTS, AS OF DECEMBER 31, 2021, WERE $46.9 MILLION

Source text for Eikon:  ID:nGNX5QVSpq 
Further company coverage:  CBIO.O 

 ((Reuters.Briefs@thomsonreuters.com;))